We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Electronic Nose Diagnoses Sleep Apnea with High Sensitivity

By LabMedica International staff writers
Posted on 29 Oct 2012
An electronic nose, which detects the presence of certain molecules in the breath of a patient, could be used to diagnose obstructive sleep apnea. More...
Electronic nose devices have been shown to distinguish between different diseases; they do this by analyzing the pattern of volatile organic compounds in breath samples

Scientists analyzed the breath of 40 sleep apnea patients and 20 healthy controls. Sleep apnea is associated with inflammation in the upper airways, which the investigators suggested could be detected by analysis of the exhaled breath of the patients. The study also aimed to assess whether the electronic nose could detect the effects of the standard treatment for sleep apnea i.e., continuous positive airway pressure (CPAP).

Questionnaires and sleep examinations confirmed sleep apnea in 40 patients. Throat washings were collected from patients to measure any improvement in their condition following treatment with CPAP. A statistical analysis model was used to calculate the accuracy of the electronic nose. The results found that the electronic nose could effectively diagnose sleep apnea. The statistical analysis showed that sleep apnea was detected with a sensitivity of 93%.

The study, which was published online on October 25, 2012 in the European Respiratory Journal could make the diagnosis of the condition quick and inexpensive compared to current methods. The gold standard used at present to identify sleep apnea is an overnight sleep test. This is technically demanding, time-consuming, and cost-intensive.

The lead author, Dr. Timm Greulich, from the Marburg Hospital (Germany) said, "This is the first time an electronic nose has been tested in the setting of sleep apnea diagnosis. The electronic nose could be useful in two ways. First, it can rule out the disease in a low prevalence population. Secondly, in a population with a high risk of sleep apnea, the device could be used to help decide who would need to undergo an overnight sleep examination. Following these results, we foresee that the use of an electronic nose could reduce costs by more appropriately selecting patients who require the sleep examination."

Related Links:

Marburg Hospital



New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
New
Electrolyte Analyzer
BKE-B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.